Batavia Bioservices BV and Xendo BV have announced that they have initiated a strategic business collaboration. As a consequence, all Bioprocess activities of Xendo Manufacturing BV have been transferred to Batavia Bioservices BV.
This provides Batavia Bioservices BV access to unique simulated moving bed (SMB) purification technology as well as infrastructure, knowledge and experience in microbial process and product development.
At the same time, the companies will establish joint marketing efforts whereby Xendo BV will provide engineering, regulatory and clinical support services and Batavia Bioservices will provide process development and analytical services.
Menzo Havenga, CEO Batavia Bioservices BV, explains: “Xendo BV and Batavia Bioservices BV together have more critical mass and therefore are able to execute larger, more complex customer programs. It is fully expected that our collaboration will result in more customers being offered a complete development services package.”
André van de Sande, CEO Xendo BV, adds: “I trust that by combining our forces both companies are better positioned to service our customers. This helps Xendo BV, both in the Netherlands and international, to further expand.”